Reich Kristian
Chief Scientific Officer at MLTX
- Sold, on record
- $19.5M
- Dollars the filings state
- Form 4 sales
- 9
- Latest Jul 27, 2026
- Form 144 notices
- 4
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- MLTXMoonLake ImmunotherapeuticsChief Scientific Officer
Sales by reason
Form 4 sales per month, every sale on record.
Timeline
- 1 Form 4 sale MLTXUnusualDec 9, 2025 2025
Sold 202,908 shares at $14.85 ($3M)
Reich Kristian, Chief Scientific Officer
No 10b5-1 planSold 100% of holdings ($3M position)0 shares left3.4x usual sizeFollows a Form 144Filing
- 2 Form 144 notice MLTXNoticeJun 15, 2026 +188 days
Filed to sell 150,000 shares ($2.9M)
Reich Kristian, Officer
10b5-1 planFiling
- 3 Form 4 sale MLTXRoutineJun 17, 2026 +2 days
Sold 150,000 shares at $19.01 ($2.9M)
Reich Kristian, Chief Scientific Officer
10b5-1 planSold 5% of holdings ($56.5M position)2.8M shares leftFollows a Form 144Filing
- 4 Form 144 notice MLTXNoticeJul 15, 2026 +28 days
Filed to sell 150,000 shares ($2.9M)
Reich Kristian, Officer
10b5-1 planFiling
- 5 Form 4 sale MLTXRoutineJul 15, 2026 same day
Sold 16,105 shares at $20.01 ($322k)
Reich Kristian, Chief Scientific Officer
10b5-1 planSold 0.6% of holdings ($56.5M position)2.8M shares leftFollows a Form 144Filing
- 6 Form 4 sale MLTXRoutineJul 20, 2026 +5 days
Sold 43,700 shares at $20.09 ($878k)
Reich Kristian, Chief Scientific Officer
10b5-1 planSold 1.6% of holdings ($56.4M position)2.8M shares left0.3x usual sizeFollows a Form 144Filing
- 7 Form 4 sale MLTXRoutineJul 22, 2026 +2 days
Sold 52,448 shares at $20.02 ($1M)
Reich Kristian, Chief Scientific Officer
10b5-1 planSold 1.9% of holdings ($55.3M position)2.7M shares left0.5x usual sizeFollows a Form 144Filing
- 8 Form 4 sale MLTXRoutineJul 27, 2026 +5 days
Sold 1,100 shares at $20.00 ($22k)
Reich Kristian, Chief Scientific Officer
10b5-1 planSold 0% of holdings ($54.2M position)2.7M shares left0x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (13)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | Jul 29, 2026 | MLTX | Chief Scientific Officer | Form 4 sale | 1,100 | $22k | 0.0% | Routine | SEC |
| Jul 22, 2026 | Jul 23, 2026 | MLTX | Chief Scientific Officer | Form 4 sale | 52,448 | $1M | 1.9% | Routine | SEC |
| Jul 20, 2026 | Jul 21, 2026 | MLTX | Chief Scientific Officer | Form 4 sale | 43,700 | $878k | 1.6% | Routine | SEC |
| Jul 15, 2026 | Jul 20, 2026 | MLTX | Chief Scientific Officer | Form 4 sale | 16,105 | $322k | 0.6% | Routine | SEC |
| Jul 15, 2026 | Jul 15, 2026 | MLTX | Officer | Form 144 notice | 150,000 | $2.9M | Notice | SEC | |
| Jun 17, 2026 | Jun 17, 2026 | MLTX | Chief Scientific Officer | Form 4 sale | 150,000 | $2.9M | 5.0% | Routine | SEC |
| Jun 15, 2026 | Jun 15, 2026 | MLTX | Officer | Form 144 notice | 150,000 | $2.9M | Notice | SEC | |
| Dec 9, 2025 | Dec 10, 2025 | MLTX | Chief Scientific Officer | Form 4 sale | 202,908 | $3M | 100.0% | Unusual | SEC |
| Dec 8, 2025 | Dec 8, 2025 | MLTX | Officer, Director, Chief Scientific Officer | Form 144 notice | 202,908 | $3M | Notice | SEC | |
| Feb 28, 2024 | Feb 29, 2024 | MLTX | Chief Scientific Officer | Form 4 sale | 118,922 | $6.5M | 3.9% | Routine | SEC |
| Feb 21, 2024 | Feb 22, 2024 | MLTX | Chief Scientific Officer | Form 4 sale | 21,078 | $1.2M | 0.7% | Routine | SEC |
| Feb 16, 2024 | Feb 16, 2024 | MLTX | Chief Scientific Officer | Form 4 sale | 60,000 | $3.7M | 2.0% | Routine | SEC |
| Feb 14, 2024 | Feb 14, 2024 | MLTX | Officer, CSO | Form 144 notice | 200,000 | $12.6M | Notice | SEC |